Loading…
Lobbying Spend
—
Filings
5
Firms Hired
1
Active Period
2025–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
2026 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to developing cell and gene therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
2026 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8646
Source: Senate LDA